Optimising Mammography Screening Accuracy With Blood-based Biomarkers
Enrolling by invitation
Conditions studied: Breast Cancer
In brief
The project aims to investigate whether breast cancer screening can be improved using blood tests, thereby reducing the number of unnecessary clinical mammographies. The Danish breast cancer screening program was implemented in 2007, and currently, all women aged 50-69 are invited every two years to participate. Those who have a suspecious screening mammography are referred to a clinical mammography where further assesment with more mammographies, ultra-sound and possibly biopsies are conducted. Around 75% of the women that are referred to further assesment can be classified as unnecessary, as no breastcancer is found. This results in avoidable and unpleasant procedures for individuals and strains healthcare resources. The project seeks to reduce the number of these unnecessary clinical mammographies by investigating whether blood biomarkers can identify women at very low risk of breast cancer after a positive mammography screening. By utilizing blood tests, screening could become more personalized, precise, and resource-efficient for the healthcare system.
Key facts
- Study ID
- NCT07049822
- Run by
- Vejle Hospital
- People needed
- 1200
- Starts
- 2025-11-24
- Expected to finish
- 2029-12-31
- Last updated by the study team
- 2026-03-09
Who can join
Age: 50 and older, up to 69. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Participation in the Danish breast cancer screening program
You may not qualify if…
- No clinical mammography conducted
Where it is running
- Odense University Hospital — Odense, Denmark
- Vejle Hospital — Vejle, Denmark
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.